| Table S13 Full
retrospective analysis of retinal disease genes cloned over the last three
years This shows an analysis of retinal disease genes identified in the previous three years and how well the newly identified photoreceptor-enriched/specific genes identified by SAGE in this study would have identified them. Gene shows the LocusLink symbol for the gene in question. Location indicates the last chromosomal interval published prior to the positional cloning of the gene in question. Disease indicates the OMIM symbol for the disease associated with the gene. "In our set?" indicates whether the gene in question appeared at >0.01% in the ONL library. Category indicates the expression pattern of the cloned gene. Total PR-enriched genes in interval indicates the total number of genes identified in our study or that met 3 out of 4 Venn criteria but had not been identified at the time of the cloning of the gene. Total genes in interval is derived from genes identified by LocusLink. Total predicted genes in interval are identified by GeneScan. |
|||||||
| Retinal disease genes identified by postitional cloning | |||||||
| Gene | Location | Disease | In our set? | Category | Total PR-enriched genes in interval | Total genes in interval | Total predicted genes in interval |
| Meet 3 out of 4 or more Venn criteria | |||||||
| CACNA1F | Xp11.23 | CSNB2 | Yes | Rod-enriched | 2 | 36 | 53 |
| NR2E3 | 15q22-q24 | RP | Yes | Rod-specific | 1 | 162 | 384 |
| CNGB1 | 16q13-q21 | RP | Yes | Rod-specific | 4 | 52 | 110 |
| PROML1 | 4p | RP | Yes | Rod-enriched | 3 | 192 | 707 |
| GCAP1 | 6p21.1 | COD3 | Yes | Rod-specific | 5 | 98 | 220 |
| TULP1 | 6p21.1-tel | RP14 | Yes | Rod-specific | 11 | 528 | 1266 |
| ELOVL4 | 6q | STGD3 | Yes | Rod-enriched | 5 | 388 | 1525 |
| RP1 | 8q11-q21 | RP1 | Yes | Rod-specific | 3 | 131 | 577 |
| AIPL1 | 17p13.1 | LCA4 | Yes | Rod-specific | 6 | 27 | 81 |
| RETGC1 | 17p13.1 | LCA1 | Yes | Rod-specific | 6 | 27 | 81 |
| Shown to be PR-enriched by in situ | |||||||
| BBS2 | 16q | BBS2 | Yes | Rod-enriched | 6 | 357 | 1055 |
| Meet 1 out of 4 Venn criteria/not tested by in situ | |||||||
| PRPC8 | 17p13 | RP13 | Yes/not tested | Widespread? | 4 | 195 | 387 |
| MKKS | 20p12 | BBS6 | Yes/not tested | Rod-enriched? | 1 | 26 | 119 |
| Not identified by SAGE/other candidate genes in interval | |||||||
| PCD15 | 10 | USH1F | No | Widespread in brain/retina expression unknown | 11 | 652 | 2446 |
| CDH23 | 10q21-22 | USH1D | No/no mouse ortholog | Retina-enriched | 3 | 129 | 411 |
| CRB1 | 1q31-q32.1 | RP12 | No/no mouse 3' end | Widespread in brain/retina-enriched, but cell type unknown | 3 | 64 | 192 |
| usherin | 1q41 | USH2A | No/no mouse ortholog | Rod-specific? | 1 | 28 | 61 |
| CNGB3 | 8q21-q22 | ACHM3 | No/low abundance | Cone-specific | 1 | 92 | 347 |
| USH3 | 3p21-25 | USH3A | No/no mouse 3' end | Widespread | 2 | 202 | 642 |
| Not identified by SAGE/no candidate genes in interval | |||||||
| harmonin | 11p15 | USH1C | No/no mouse ortholog | Widespread | 0 | NA | NA |
| BBS4 | 15q22.3-q23 | BBS4 | No/low abundance | Widespread | 0 | NA | NA |
| CNGA3 | 2q11 | RM | No/no mouse 3' end | Cone-specific | 0 | NA | NA |
| NYX | Xp21 | CSNB1 | No/no mouse ortholog | Retina-enriched/all cell types | 0 | NA | NA |
| PRP31 | 19q13.4 | RP11 | Yes | Widespread | 0 | NA | NA |
| Retinal disease genes identified by association studies | |||||||
| MERTK | RP | Yes | Rod-enriched | ||||
| LRAT | RP | No | RPE-specific | ||||
| RPGRIP1 | LCA | Yes | Rod-enriched | ||||
| HGR4 | CORD | Yes | Rod-specific | ||||
| TTPA | RP | No | RPE-specific | ||||
| RGR | RP | No | RPE-specific | ||||
| RDH5 | RP | No | RPE-specific | ||||
| NR2E3 | enhanced S-cone syndrome | Yes | Rod-specific | ||||
| Median number of candidate genes/interval: | |||||||
| PR-enriched retinal disease genes | 3 | ||||||
| NonPR-enriched disease genes | 3 | ||||||